This report provides a comprehensive analysis of current global TB Disease Vaccine market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the TB Disease Vaccine industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to GRD Survey, the global TB Disease Vaccine market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global TB Disease Vaccine Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global TB Disease Vaccine market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global TB Disease Vaccine Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global TB Disease Vaccine industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions


Segmented by Type
Prevention Vaccines
Post-exposure Vaccines

Segmented by Application
Self-Procurement
UNICEF
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Queen Saovabha Mem. Inst
Microgen
Merck
Japan BCG Lab
IVAC
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
BioFarma
Ataulpho de Paiva
AJ Vaccines

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global TB Disease Vaccine Market Status and Forecast (2017-2028)
1.3.2 Global TB Disease Vaccine Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global TB Disease Vaccine Supply by Company
2.1 Global TB Disease Vaccine Sales Volume by Company
2.2 Global TB Disease Vaccine Sales Value by Company
2.3 Global TB Disease Vaccine Price by Company
2.4 TB Disease Vaccine Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional TB Disease Vaccine Market Status by Type
3.1 TB Disease Vaccine Type Introduction
3.1.1 Prevention Vaccines
3.1.2 Post-exposure Vaccines
3.1.3 Others
3.2 Global TB Disease Vaccine Market by Type
3.2.1 Global TB Disease Vaccine Sales Volume by Type (2017-2022)
3.2.2 Global TB Disease Vaccine Sales Value by Type (2017-2022)
3.2.3 Global TB Disease Vaccine Price by Type (2017-2022)
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional TB Disease Vaccine Market Status by Application
4.1 TB Disease Vaccine Segment by Application
4.1.1 Self-Procurement
4.1.2 UNICEF
4.1.3 Others
4.2 Global TB Disease Vaccine Market by Application
4.2.1 Global TB Disease Vaccine Sales Volume by Application (2017-2022)
4.2.2 Global TB Disease Vaccine Sales Value by Application (2017-2022)
4.2.3 Global TB Disease Vaccine Price by Application (2017-2022)
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global TB Disease Vaccine Market Status by Region
5.1 Global TB Disease Vaccine Market by Region
5.1.1 Global TB Disease Vaccine Sales Volume by Region
5.1.2 Global TB Disease Vaccine Sales Value by Region
5.2 North America TB Disease Vaccine Market Status
5.3 Europe TB Disease Vaccine Market Status
5.4 Asia Pacific TB Disease Vaccine Market Status
5.5 Central & South America TB Disease Vaccine Market Status
5.6 Middle East & Africa TB Disease Vaccine Market Status
6 North America TB Disease Vaccine Market Status
6.1 North America TB Disease Vaccine Market by Country
6.1.1 North America TB Disease Vaccine Sales Volume by Country (2017-2022)
6.1.2 North America TB Disease Vaccine Sales Value by Country (2017-2022)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe TB Disease Vaccine Market Status
7.1 Europe TB Disease Vaccine Market by Country
7.1.1 Europe TB Disease Vaccine Sales Volume by Country (2017-2022)
7.1.2 Europe TB Disease Vaccine Sales Value by Country (2017-2022)
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific TB Disease Vaccine Market Status
8.1 Asia Pacific TB Disease Vaccine Market by Country
8.1.1 Asia Pacific TB Disease Vaccine Sales Volume by Country (2017-2022)
8.1.2 Asia Pacific TB Disease Vaccine Sales Value by Country (2017-2022)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America TB Disease Vaccine Market Status
9.1 Central & South America TB Disease Vaccine Market by Country
9.1.1 Central & South America TB Disease Vaccine Sales Volume by Country (2017-2022)
9.1.2 Central & South America TB Disease Vaccine Sales Value by Country (2017-2022)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa TB Disease Vaccine Market Status
10.1 Middle East & Africa TB Disease Vaccine Market by Country
10.1.1 Middle East & Africa TB Disease Vaccine Sales Volume by Country (2017-2022)
10.1.2 Middle East & Africa TB Disease Vaccine Sales Value by Country (2017-2022)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 TB Disease Vaccine Manufacturing Cost Analysis
11.5 TB Disease Vaccine Sales Channel and Distributors Analysis
11.5.1 TB Disease Vaccine Sales Channel
11.5.2 TB Disease Vaccine Distributors
11.6 TB Disease Vaccine Downstream Major Buyers
12 Global TB Disease Vaccine Market Forecast by Type and by Application
12.1 Global TB Disease Vaccine Sales Volume and Sales Value Forecast (2023-2028)
12.2 Global TB Disease Vaccine Forecast by Type
12.2.1 Global TB Disease Vaccine Sales Volume Forecast by Type
12.2.2 Global TB Disease Vaccine Sales Value Forecast by Type
12.2.3 Global TB Disease Vaccine Price Forecast by Type
12.3 Global TB Disease Vaccine Forecast by Application
12.3.1 Global TB Disease Vaccine Sales Volume Forecast by Application
12.3.2 Global TB Disease Vaccine Sales Value Forecast by Application
12.3.3 Global TB Disease Vaccine Price Forecast by Application
13 Global TB Disease Vaccine Market Forecast by Region/Country
13.1 Global TB Disease Vaccine Market Forecast by Region (2023-2028)
13.1.1 Global TB Disease Vaccine Sales Volume Forecast by Region (2023-2028)
13.1.2 Global TB Disease Vaccine Sales Value Forecast by Region (2023-2028)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Taj Pharmaceuticals
14.1.1 Company Information
14.1.2 TB Disease Vaccine Product Introduction
14.1.3 Taj Pharmaceuticals TB Disease Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.1.4 SWOT Analysis
14.2 Serum Institute of India
14.2.1 Company Information
14.2.2 TB Disease Vaccine Product Introduction
14.2.3 Serum Institute of India TB Disease Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.2.4 SWOT Analysis
14.3 Queen Saovabha Mem. Inst
14.3.1 Company Information
14.3.2 TB Disease Vaccine Product Introduction
14.3.3 Queen Saovabha Mem. Inst TB Disease Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.3.4 SWOT Analysis
14.4 Microgen
14.4.1 Company Information
14.4.2 TB Disease Vaccine Product Introduction
14.4.3 Microgen TB Disease Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.4.4 SWOT Analysis
14.5 Merck
14.5.1 Company Information
14.5.2 TB Disease Vaccine Product Introduction
14.5.3 Merck TB Disease Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.5.4 SWOT Analysis
14.6 Japan BCG Lab
14.6.1 Company Information
14.6.2 TB Disease Vaccine Product Introduction
14.6.3 Japan BCG Lab TB Disease Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.6.4 SWOT Analysis
14.7 IVAC
14.7.1 Company Information
14.7.2 TB Disease Vaccine Product Introduction
14.7.3 IVAC TB Disease Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.7.4 SWOT Analysis
14.8 GreenSignal Bio Pharma
14.8.1 Company Information
14.8.2 TB Disease Vaccine Product Introduction
14.8.3 GreenSignal Bio Pharma TB Disease Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.8.4 SWOT Analysis
14.9 China National Biotec
14.9.1 Company Information
14.9.2 TB Disease Vaccine Product Introduction
14.9.3 China National Biotec TB Disease Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.9.4 SWOT Analysis
14.10 Biomed Lublin
14.10.1 Company Information
14.10.2 TB Disease Vaccine Product Introduction
14.10.3 Biomed Lublin TB Disease Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.10.4 SWOT Analysis
14.11 BioFarma
14.12 Ataulpho de Paiva
14.13 AJ Vaccines
15 Conclusion
16 Methodology